article_metadata: Yeshan Chen Ai Huang Qin Yang Jing Yu Guiling Li
article_metadata: 10.3389/fimmu.2022.987345
article_metadata: Front Immunol
article_metadata: 2022 Oct 6;13:987345.
article_metadata: gls-010 endometrial cancer immune checkpoint inhibitors myocarditis re-challenge
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/36275726/
article_metadata: Antineoplastic Agents, Immunological / adverse effects Endometrial Neoplasms / drug therapy
article_metadata: Antineoplastic Agents, Immunological / adverse effects Endometrial Neoplasms / drug therapy Case Reports Antibodies, Monoclonal B7-H1 Antigen Female Humans Immune Checkpoint Inhibitors / adverse effects Immunologic Factors Neoplasm Recurrence, Local / drug therapy Programmed Cell Death 1 Receptor Programmed Cell Death 1 Receptor Immune Checkpoint Inhibitors Antineoplastic Agents, Immunological B7-H1 Antigen zimberelimab Antibodies, Monoclonal Immunologic Factors
article_metadata: PMC9582132
article_metadata: 36275726
article_metadata: Case report: A successful re-challenge report of GLS-010 (Zimberelimab), a novel fully humanized mAb to PD-1, in a case of recurrent endometrial cancer
article_metadata: 2022